Nanjing BioPoint Diagnostic Technology
PrivateLast Round
Seed
Apr 14, 2014
Total Funding Raised
$240,000
Company Overview
Nanjing BioPoint Diagnostic Technology is a medical technology company that develops and manufactures point-of-care diagnostic tests and devices.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotechnology
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Nanjing BioPoint Diagnostic Technology Comparables
Compare Nanjing BioPoint Diagnostic Technology with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Premier Medical Corporation | 80% | |
| Diagnostics For All | 80% | |
| Sedia Biosciences Corporation | 79% |
Nanjing BioPoint Diagnostic Technology Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Apr 14, 2014 |
Nanjing BioPoint Diagnostic Technology Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Nanjing Municipal Government | Grant |
| Beijing Guominxinhe Group | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 14, 2014
Seed round with investors including Beijing Guominxinhe Group and Burnet Institute.
Nanjing BioPoint Diagnostic Technology Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Nanjing BioPoint Diagnostic Technology's valuation, stock price, and market status.
Is Nanjing BioPoint Diagnostic Technology a public or private company?
Nanjing BioPoint Diagnostic Technology is a private company.
What is the current stock price of Nanjing BioPoint Diagnostic Technology?
Nanjing BioPoint Diagnostic Technology is a private company with no public stock price. Caplight tracks Nanjing BioPoint Diagnostic Technology's secondary market activity and provides MarketPrice™ estimates to Caplight users.
How much is Nanjing BioPoint Diagnostic Technology worth (valuation)?
Valuation information for Nanjing BioPoint Diagnostic Technology is not publicly available.
Can I buy Nanjing BioPoint Diagnostic Technology stock?
Nanjing BioPoint Diagnostic Technology shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Nanjing BioPoint Diagnostic Technology's last funding round?
Nanjing BioPoint Diagnostic Technology's most recent funding round was Seed on April 14, 2014.
Who are the main investors in Nanjing BioPoint Diagnostic Technology?
Key investors in Nanjing BioPoint Diagnostic Technology include Nanjing Municipal Government, Beijing Guominxinhe Group.
Will Nanjing BioPoint Diagnostic Technology IPO soon?
No public IPO plans have been announced for Nanjing BioPoint Diagnostic Technology.
How can I track Nanjing BioPoint Diagnostic Technology secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Nanjing BioPoint Diagnostic Technology's secondary market activity and sign up for updates.